Bristol-Myers Squibb has agreed to acquire RayzeBio Inc. for $4.1 billion. The transaction, announced Dec. 26, is expected to close in the first half of 2024. New York-based Bristol-Myers was advised by Covington & Burling. RayzeBio, which is based in San Diego, was represented by Cooley.
Biotech & Pharmaceuticals
December 29, 2023, 6:11 PM